24 results
6-K
EX-99.1
SPRC
SciSparc Ltd
19 Mar 19
Therapix Biosciences Appoints Ambassador Ron Prosor as Executive Advisor
8:04am
prove beneficial for achieving our goals both in the short and long terms.”
“I am excited by the opportunity to be part of the promising technology … development of Therapix and to be part of achieving the Company’s goals in reaching new heights,” said Ambassador Prosor, and added “I believe
6-K
EX-99.2
SPRC
SciSparc Ltd
29 Sep 23
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
7:46am
, Israel’s foremost authority on autism research, underscores our unwavering commitment to scientific rigor and patient safety. Our goals are to create … . For example, SciSparc is using forward-looking statements when it discusses: the goals and objectives of the SCI-210 clinical trial; and the Company’s
6-K
EX-99.1
SPRC
SciSparc Ltd
6 Jan 22
Report of Foreign Private Issuer
4:02pm
-term goals and performance, and as a result, with those of our shareholders.
Pursuant to the Proposed Compensation Policy, the compensation that may … to reach its business and financial long-term goals. Accordingly, the structure of this Policy is established to tie the compensation of each officer
6-K
EX-99.2
SPRC
SciSparc Ltd
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
forward-looking statements when it discusses its future plans and goals, including reaching the company’s potential, providing value to shareholders
6-K
meonn
28 Nov 23
Report of Foreign Private Issuer
4:01pm
F-1
EX-10.7
n2wgcl k162x53
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
2vlzwukeahvlcmq60zn
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
6-K
EX-99.1
v7f1d5b6krai hyjqq
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
425
ye4eqwr6
2 May 24
Business combination disclosure
4:46pm
F-1/A
j2khsal
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
btjzjt
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B4
k2myz9avgm
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
5exc5iz1v
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
2941a4eqvhj
26 Mar 20
Registration statement (foreign) (amended)
12:00am
20-F
28h1kb8 46wt
1 May 17
Annual report (foreign)
12:00am